1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. n.d. DOI: 10.3322/caac.21492
2. Jacques F, Isabelle S, Rajesh D, Sultan E, Colin M, Marise R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136:E359-E386. DOI: 10.1002/ijc.29210
3. Malvezzi M, Carioli G, Rodriguez T, Negri E, La Vecchia C. Global trends and predictions in ovarian cancer mortality. 2016;27. DOI: 10.1093/annonc/mdw306
4. Kumar B, Davies-Humphreys J. Tumour markers and ovarian cancer screening. The Obstetrician and Gynaecologist. 2011;2:41-44. DOI: 10.1576/toag.2000.2.4.41
5. Alberico S, Facca MC, Millo R, Radillo L, Mandruzzato GP. Tumoral markers (CA 125--CEA) in the screening of ovarian cancer. European Journal of Gynaecological Oncology. 1988;9:485-489